Product Name

  • Name

    CLOPERASTINE

  • EINECS
  • CAS No. 3703-76-2
  • Article Data2
  • CAS DataBase
  • Density 1.12g/cm3
  • Solubility
  • Melting Point
  • Formula C20H24 Cl N O
  • Boiling Point 423.9°Cat760mmHg
  • Molecular Weight 329.87
  • Flash Point 210.2°C
  • Transport Information
  • Appearance
  • Safety Poison by intraperitoneal route. Moderately toxic by ingestion. When heated to decomposition it emits toxic fumes of Cl and NOx.
  • Risk Codes
  • Molecular Structure Molecular Structure of 3703-76-2 (CLOPERASTINE)
  • Hazard Symbols
  • Synonyms Piperidine,1-[2-[(p-chloro-a-phenylbenzyl)oxy]ethyl]-(6CI,7CI,8CI); (?à)-Cloperastine;1-[2-[(p-Chloro-a-phenylbenzyl)oxy]ethyl]piperidine;Cloperastine; p-Chlorobenzhydryl 2-(1-piperidyl)ethyl ether
  • PSA 12.47000
  • LogP 4.86980

Synthetic route

piperidine
110-89-4

piperidine

(4-chlorophenyl)phenylmethyl 2-chloroethyl ether
5321-46-0, 132301-88-3

(4-chlorophenyl)phenylmethyl 2-chloroethyl ether

Cloperastine
3703-76-2

Cloperastine

Conditions
ConditionsYield
With sodium carbonate at 95℃; for 14h;80.7%
(4-chlorophenyl)phenylmethanol
119-56-2

(4-chlorophenyl)phenylmethanol

Cloperastine
3703-76-2

Cloperastine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sulfuric acid / toluene / 5 h / Reflux
2: sodium carbonate / 14 h / 95 °C
View Scheme
Cloperastine
3703-76-2

Cloperastine

2-<(2'-hydroxy-5'-biphenylyl)carbonyl>benzoic acid
84627-04-3

2-<(2'-hydroxy-5'-biphenylyl)carbonyl>benzoic acid

levocloperastine fendizoate

levocloperastine fendizoate

Conditions
ConditionsYield
In water; acetone for 2h; Solvent; Reflux;96.2%
triethyl(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)silane
745783-97-5

triethyl(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)silane

Cloperastine
3703-76-2

Cloperastine

1-(2-(phenyl(4-(triethylsilyl)phenyl)methoxy)ethyl)piperidine

1-(2-(phenyl(4-(triethylsilyl)phenyl)methoxy)ethyl)piperidine

Conditions
ConditionsYield
With 3,4,7,8-Tetramethyl-o-phenanthrolin; ferrous iodide; sodium t-butanolate In tetrahydrofuran at 120℃; for 12h; Schlenk technique; Glovebox; Inert atmosphere;88%
Cloperastine
3703-76-2

Cloperastine

2-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-3-methylbutanoic acid chloromethyl ester

2-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-3-methylbutanoic acid chloromethyl ester

1-[2-[(4-chlorophenyl)phenylmethoxy]ethyl]-1-[[2-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-3-methyl-1-oxobutoxy]methyl]piperidinium chloride

1-[2-[(4-chlorophenyl)phenylmethoxy]ethyl]-1-[[2-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-3-methyl-1-oxobutoxy]methyl]piperidinium chloride

Conditions
ConditionsYield
In dichloromethane at 70℃; for 1h;85%
Cloperastine
3703-76-2

Cloperastine

C20H13(2)H11ClNO*ClH

C20H13(2)H11ClNO*ClH

Conditions
ConditionsYield
Stage #1: Cloperastine With water-d2; lithium carbonate; triisopropylsilanethiol In 1-methyl-pyrrolidin-2-one at 20℃; Irradiation;
Stage #2: With hydrogenchloride In 1-methyl-pyrrolidin-2-one
78%
Cloperastine
3703-76-2

Cloperastine

3-[[(1,1-dimethylethoxy)carbonyl]amino]-2,2-dimethylpropanoic acid iodomethyl ester

3-[[(1,1-dimethylethoxy)carbonyl]amino]-2,2-dimethylpropanoic acid iodomethyl ester

1-[2-[(4-chlorophenyl)phenylmethoxy]ethyl]-1-[[3-[[(1,1-dimethylethoxy)carbonyl]amino]-2,2-dimethyl-1-oxopropoxy]methyl]piperidinium iodide

1-[2-[(4-chlorophenyl)phenylmethoxy]ethyl]-1-[[3-[[(1,1-dimethylethoxy)carbonyl]amino]-2,2-dimethyl-1-oxopropoxy]methyl]piperidinium iodide

Conditions
ConditionsYield
In dichloromethane at 70℃; for 3h;78%
Cloperastine
3703-76-2

Cloperastine

sodium trimethylsilyldimethylsilanolate

sodium trimethylsilyldimethylsilanolate

1-(2-(phenyl(4-trimethylsilylphenyl)methoxy)ethyl)piperidine

1-(2-(phenyl(4-trimethylsilylphenyl)methoxy)ethyl)piperidine

Conditions
ConditionsYield
With bis(1,5-cyclooctadiene)nickel (0); Dimethyl(phenyl)phosphine In toluene at 70℃; for 18h; Schlenk technique; Sealed tube;59%
Cloperastine
3703-76-2

Cloperastine

levocloperastine

levocloperastine

Conditions
ConditionsYield
With di-p-anisoyl-L-tartaric acid In ethanol at 60℃; for 2h;
Cloperastine
3703-76-2

Cloperastine

C20H13(3)H11ClNO

C20H13(3)H11ClNO

Conditions
ConditionsYield
With tritium oxide In 1-methyl-pyrrolidin-2-one at 20℃; Irradiation;
Cloperastine
3703-76-2

Cloperastine

(E)-1-ethyl-5,5-dimethyl-2-(4,4,4-trifluorobut-2-enoyl)pyrazolidin-3-one

(E)-1-ethyl-5,5-dimethyl-2-(4,4,4-trifluorobut-2-enoyl)pyrazolidin-3-one

A

2-((3S)-3-(1-(2-((4-chlorophenyl)(phenyl)methoxy)ethyl)-1,4,5,6-tetrahydropyridin-3-yl)-4,4,4-trifluorobutanoyl)-1-ethyl-5,5-dimethylpyrazolidin-3-one

2-((3S)-3-(1-(2-((4-chlorophenyl)(phenyl)methoxy)ethyl)-1,4,5,6-tetrahydropyridin-3-yl)-4,4,4-trifluorobutanoyl)-1-ethyl-5,5-dimethylpyrazolidin-3-one

B

2-(3-(1-(2-((4-chlorophenyl)(phenyl)methoxy)ethyl)-1,4,5,6-tetrahydropyridin-3-yl)-4,4,4-trifluorobutanoyl)-1-ethyl-5,5-dimethylpyrazolidin-3-one

2-(3-(1-(2-((4-chlorophenyl)(phenyl)methoxy)ethyl)-1,4,5,6-tetrahydropyridin-3-yl)-4,4,4-trifluorobutanoyl)-1-ethyl-5,5-dimethylpyrazolidin-3-one

Conditions
ConditionsYield
With tris(pentafluorophenyl)borate; scandium tris(trifluoromethanesulfonate); 2,6-bis[(4S,6S)-sec-butyl-2-oxazolin-2-yl]pyridine In dichloromethane at 80℃; for 24h; Inert atmosphere; stereoselective reaction;A n/a
B n/a

CLOPERASTINE Chemical Properties

Product Name: Cloperastine (CAS NO.3703-76-2)


Molecular Formula: C20H24ClNO
Molecular Weight: 329.86g/mol
Mol File: 3703-76-2.mol
Einecs: 223-042-3
Boiling point: 423.9 °C at 760 mmHg
Storage Temperature:
Flash Point: 210.2 °C
Density: 1.12 g/cm3
Surface Tension: 42.1 dyne/cm
Enthalpy of Vaporization: 67.83 kJ/mol
Vapour Pressure: 2.15E-07 mmHg at 25°C
XLogP3-AA: 4.8
H-Bond Donor: 0
H-Bond Acceptor: 2

CLOPERASTINE Toxicity Data With Reference

1.    

orl-rat LD50:2325 mg/kg

    NIIRDN    “Drugs in Japan. Ethical Drugs, 6th Edition 1982“ Edited by Japan Pharmaceutical Information Center. 6 (1982),241.
2.    

ipr-rat LD50:120 mg/kg

    NIIRDN    “Drugs in Japan. Ethical Drugs, 6th Edition 1982“ Edited by Japan Pharmaceutical Information Center. 6 (1982),241.
3.    

orl-mus LD50:600 mg/kg

    NIIRDN    “Drugs in Japan. Ethical Drugs, 6th Edition 1982“ Edited by Japan Pharmaceutical Information Center. 6 (1982),241.
4.    

ipr-mus LD50:96 mg/kg

    NIIRDN    “Drugs in Japan. Ethical Drugs, 6th Edition 1982“ Edited by Japan Pharmaceutical Information Center. 6 (1982),241.

CLOPERASTINE Safety Profile

Poison by intraperitoneal route. Moderately toxic by ingestion. When heated to decomposition it emits toxic fumes of Cl and NOx.

CLOPERASTINE Specification

 Cloperastine ,its CAS NO. is 3703-76-2,the synonyms is 1-(2-((4-Chlorophenyl)phenylmethoxy)ethyl)-piperidin ; 1-(2-((4-Chlorophenyl)phenylmethoxy)ethyl)piperidine ; 1-(2-((p-Chloro-alpha-phenylbenzyl)oxy)ethyl)-piperidin ; 1-(2-[(4-Chlorophenyl)(phenyl)methoxy]ethyl)piperidine ; 1-[2-[p-Chloro-phenylbenzyl)-oxy]ethy]piperidine ; 1-{2-[(p-Chloro-alpha-phenylbenzyl)oxy]ethyl}piperidine ; Piperidine, 1-(2-((p-chloro-alpha-phenylbenzyl)oxy)ethyl)- .

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View